• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION WATCHMAN LAA CLOSURE DEVICE & DELIVERY SYSTEM; SYSTEM, APPENDAGE CLOSURE, LEFT ATRIAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION WATCHMAN LAA CLOSURE DEVICE & DELIVERY SYSTEM; SYSTEM, APPENDAGE CLOSURE, LEFT ATRIAL Back to Search Results
Model Number 10371
Device Problem Device Dislodged or Dislocated (2923)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 11/15/2019
Event Type  Injury  
Event Description
It was reported that a device embolization occurred.A left atrial appendage (laa) closure procedure was being performed.A watchman access system (was) was positioned and a 21mm watchman laa closure device & delivery system (wds) were used.The closure device was deployed in the laa of the patient.The physician checked the release criteria of the device and after successfully meeting all criteria the device was released.Upon release, the position of the device changed in such a way that it needed to be removed as it was not safe to leave in the patient.The was exchanged for a 20fr sheath across the septum and multiple attempts were made to snare the device into the sheath.The device was dislodged from the appendage, travelled down into the left ventricle and through the aortic valve.The physician had earlier obtained access in the right femoral artery.The watchman access sheath was inserted into the femoral artery to reach the device in the descending aorta.The device was successfully removed from the descending aorta and removed from the patient.The patient was checked and monitored and no trauma had been inflicted on the patient throughout the process.The patient remained stable throughout the entire procedure and there was no signs of pericardial effusion or other complications.
 
Event Description
It was reported that a device embolization occurred.A left atrial appendage (laa) closure procedure was being performed.A watchman access system (was) was positioned and a 21mm watchman laa closure device & delivery system (wds) were used.The closure device was deployed in the laa of the patient.The physician checked the release criteria of the device and after successfully meeting all criteria the device was released.Upon release, the position of the device changed in such a way that it needed to be removed as it was not safe to leave in the patient.The was was exchanged for a 20fr sheath across the septum and multiple attempts were made to snare the device into the sheath.The device was dislodged from the appendage, travelled down into the left ventricle and through the aortic valve.The physician had earlier obtained access in the right femoral artery.The watchman access sheath was inserted into the femoral artery to reach the device in the descending aorta.The device was successfully removed from the descending aorta and removed from the patient.The patient was checked and monitored and no trauma had been inflicted on the patient throughout the process.The patient remained stable throughout the entire procedure and there was no signs of pericardial effusion or other complications.It was further reported that there were no further attempts to complete the procedure that day.The patient was discharged home the next day.
 
Manufacturer Narrative
Date of event corrected from (b)(6) 2019 to (b)(6) 2019.Implant date corrected from (b)(6) 2019 to (b)(6) 2019.Explant date corrected from (b)(6) 2019 to (b)(6) 2019.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
WATCHMAN LAA CLOSURE DEVICE & DELIVERY SYSTEM
Type of Device
SYSTEM, APPENDAGE CLOSURE, LEFT ATRIAL
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
MDR Report Key9477219
MDR Text Key171647236
Report Number2134265-2019-15425
Device Sequence Number1
Product Code NGV
UDI-Device Identifier08714729838227
UDI-Public08714729838227
Combination Product (y/n)N
PMA/PMN Number
P130013
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup
Report Date 01/03/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date07/07/2022
Device Model Number10371
Device Catalogue Number10371
Device Lot Number0024072434
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 11/22/2019
Initial Date FDA Received12/16/2019
Supplement Dates Manufacturer Received12/18/2019
Supplement Dates FDA Received01/03/2020
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-